On the opposite, in subjects without actively replicating HCV infection, the mechanism(s) that regulate the occurrence of steatosis seem to be independent from IL28B polymorphism but purely related to the lipid disturbance occurring in non-alcoholic fatty liver disease, which remains one of the most important clinical features of metabolic syndrome [35]. The gene discussed is IFNL3; the disease is steatosis.